General Information of the Compound
| Compound ID |
CP0482019
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-[4-[7-(trifluoromethyl)quinolin-4-yl]piperazin-1-yl]butyl]imidazo[1,2-a]pyridine-2-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H27F3N6O
|
||||||||||||||||||
| Molecular Weight |
496.537
|
||||||||||||||||||
| Canonical SMILES |
FC(F)(F)c1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H27F3N6O/c27-26(28,29)19-6-7-20-21(17-19)30-10-8-23(20)34-15-13-33(14-16-34)11-4-2-9-31-25(36)22-18-35-12-3-1-5-24(35)32-22/h1,3,5-8,10,12,17-18H,2,4,9,11,13-16H2,(H,31,36)
Show/Hide
|
||||||||||||||||||
| InChIKey |
HZTKYJRCVZENNH-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor